6505--Losartan Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0032
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Michael J Olszewski michael.olszewski@va.gov (708) 786-4996
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0032 for Losartan Potassium Tablets, which will serve multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The procurement will be an unrestrictive, commercial item format solicitation under FAR Part 12, with the VA planning to award a single contract to a responsible offeror capable of providing an uninterrupted supply of the specified pharmaceutical products. Offerors must precisely identify the drug name as it appears on the label and provide a unique NDC number. The solicitation will be electronically issued on May 6, 2025, with a tentative closing date of May 20, 2025. Interested parties can submit questions via email to Michael Olszewski at Michael.Olszewski@va.gov, and all documents will be available for download on beta.sam.gov.
The contract will have an initial one-year period with four additional pre-priced one-year option periods, categorized under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The estimated annual usage encompasses nine different Losartan tablet configurations, ranging from 25mg to 100mg tablets, with package sizes of 30, 90, and 1,000 tablets per bottle. Total estimated annual usage varies by configuration, with the highest demand for 90-tablet bottles of 50mg and 100mg tablets, reaching 564,328 and 647,231 bottles respectively. The distribution will occur through the VA's Pharmaceutical Prime Vendor Programs, and no specific set-aside has been designated for this procurement. All responsible sources are invited to submit timely offers, with the government seeking a vendor who can comprehensively meet the specified pharmaceutical requirements across multiple federal agencies.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0032 for an unrestrictive procurement for Losartan Potassium Tablets. for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation #36E79725R0032 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 6, 2025, with a tentative closing date of May 20, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov.
The estimated annual requirements are as follows:
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATEDANNUAL USAGE
(Bottles)
1
LOSARTAN 25MG TAB
30
165,917
2
LOSARTAN 25MG TAB
90
257,393
3
LOSARTAN 25MG TAB
1,000
43,955
4
LOSARTAN 50MG TAB
30
60,715
5
LOSARTAN 50MG TAB
90
564,328
6
LOSARTAN 50MG TAB
1,000
53,509
7
LOSARTAN 100MG TAB
30
60,796
8
LOSARTAN 100MG TAB
90
647,231
9
LOSARTAN 100MG TAB
1,000
62,925
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79725R0032_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Losartan Tablets | Award Notice | |
| 6505--Losartan Tablets | Solicitation | |
| 6505--Losartan Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity